Sensei Biotherapeutics, Inc. (SNSE)

Sensei Biotherapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-31.92	-34.1	-48.59	-36.79	-20.1	-16.74
Depreciation & Amortization	1.32	1.35	1.35	0.69	0.21	0.07
Loss (Gain) From Sale of Assets	0.21	0.3	-0.02	-0.03	-	-
Loss (Gain) From Sale of Investments	-0.82	-1.06	0.22	0.62	-	-
Stock-Based Compensation	4.46	4.45	5.81	5.66	1.49	1.18
Other Operating Activities	1.41	1.36	1.19	-0.51	1.09	3.45
Change in Accounts Payable	-2.27	-2.33	2.02	-1.43	0.34	1.66
Change in Other Net Operating Assets	-0.3	-2	-1.01	1.54	-0.73	1.81
Operating Cash Flow	-27.9	-32.02	-39.03	-30.26	-17.71	-8.57
Capital Expenditures	-0.07	-0.18	-0.32	-2.03	-1.21	-0.05
Sale of Property, Plant & Equipment	0.16	0.17	0.02	0.32	-	-
Cash Acquisitions	-	-	-	-	-0.2	-
Investment in Securities	41.78	38.43	50.26	-141.41	-	-
Investing Cash Flow	41.87	38.41	49.95	-143.12	-1.4	-0.05
Short-Term Debt Issued	-	-	-	-	-	3.75
Long-Term Debt Issued	-	-	-	-	0.57	4.35
Total Debt Issued	-	-	-	-	0.57	8.1
Long-Term Debt Repaid	-	-0.76	-0.63	-0.26	-0.04	-0.03
Total Debt Repaid	-0.77	-	-	-	-	-
Net Debt Issued (Repaid)	-0.77	-0.76	-0.63	-0.26	0.53	8.07
Issuance of Common Stock	0.05	0.05	0.34	140.7	0.02	0.15
Repurchase of Common Stock	-10.39	-10.46	-	-	-	-
Other Financing Activities	-	-	-	-	-2.11	-
Financing Cash Flow	-11.12	-11.17	-0.29	163.94	35.45	8.22
Net Cash Flow	2.85	-4.78	10.64	-9.44	16.35	-0.4
Free Cash Flow	-27.97	-32.2	-39.35	-32.29	-18.91	-8.62
Free Cash Flow Per Share	-1.06	-1.15	-1.28	-1.17	-11.73	-23.48
Levered Free Cash Flow	-17.88	-21.32	-22.49	-17.56	-16.35	-3.92
Unlevered Free Cash Flow	-17.8	-21.23	-22.36	-17.14	-15.29	-2.51
Change in Net Working Capital	1.83	3.75	-2.17	-1.97	4.09	-4.07

Source: S&P Capital IQ. Standard template.